These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9411661)

  • 41. [Physiopathology of asthma: what role for leukotrienes?].
    Lockhart A; Dinh-Xuan AT
    Rev Pneumol Clin; 1997; 53(3):119-27. PubMed ID: 9296112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New drugs in asthma treatment. Leukotriene receptor blockers and leukotriene synthesis inhibitors].
    Männistö J; Haahtela T
    Nord Med; 1997 Apr; 112(4):122-5. PubMed ID: 9198809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapy of asthma: anti-inflammatory effects of antileukotrienes].
    Ukena D
    Med Klin (Munich); 1997 Dec; 92 Suppl 5():37-40. PubMed ID: 19479395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [New developments in the treatment of bronchial asthma: leukotriene inhibitors].
    Tsoĭ AN; Shor OA
    Ter Arkh; 1997; 69(2):83-8. PubMed ID: 9173590
    [No Abstract]   [Full Text] [Related]  

  • 45. [Zafirlukast (Accolate): a review of its pharmacological and clinical profile].
    Murata Y; Sugimoto O
    Nihon Yakurigaku Zasshi; 2002 Apr; 119(4):247-58. PubMed ID: 11979731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Substances affecting the synthesis and activity of leukotrienes].
    Opletalová V; Hartl J; Bĕhounková M
    Ceska Slov Farm; 1997 Apr; 46(2):51-7. PubMed ID: 9244564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of asthma with zafirlukast. Clinical experience and tolerability profile.
    Spector SL
    Drugs; 1996; 52 Suppl 6():36-46. PubMed ID: 8941502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Potential importance of antileukotrienes in the treatment of asthma and other inflammatory diseases: apropos of a new pharmacological class].
    Santais MC; Callens E; Djebbar R; Ruff F
    Rev Med Interne; 1998 Feb; 19(2):98-107. PubMed ID: 9775124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anti-leukotriene agents: rationale for and prospects of use].
    Passalacqua G; Ciprandi G; Scordamaglia A; Canonica GW
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():93S-96S. PubMed ID: 9004830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New frontiers in asthma therapy: leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Introduction.
    Hendeles L
    Pharmacotherapy; 1997; 17(1 Pt 2):1S-2S. PubMed ID: 9017782
    [No Abstract]   [Full Text] [Related]  

  • 51. Antileukotriene drugs: clinical application, effectiveness and safety.
    Riccioni G; Bucciarelli T; Mancini B; Di Ilio C; D'Orazio N
    Curr Med Chem; 2007; 14(18):1966-77. PubMed ID: 17691939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Anti-leukotrienes: a new perspective in treatment of bronchial asthma].
    Magnussen H; Richter K; Rabe KF
    Pneumologie; 1997 Sep; 51(9):877-84. PubMed ID: 9411442
    [No Abstract]   [Full Text] [Related]  

  • 53. Leukotriene modifiers: novel therapeutic opportunities in asthma.
    Buccellati C; Fumagalli F; Viappiani S; Folco G
    Farmaco; 2002 Mar; 57(3):235-42. PubMed ID: 11989802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leukotriene generation and clinical implications.
    Arm JP
    Allergy Asthma Proc; 2004; 25(1):37-42. PubMed ID: 15055561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.
    Claesson HE; Dahlén SE
    J Intern Med; 1999 Mar; 245(3):205-27. PubMed ID: 10205583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antileukotrienes--1997 and beyond.
    Spector SL
    West J Med; 1997 Nov; 167(5):345-6. PubMed ID: 9392986
    [No Abstract]   [Full Text] [Related]  

  • 57. Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function.
    Theron AJ; Steel HC; Tintinger GR; Gravett CM; Anderson R; Feldman C
    J Immunol Res; 2014; 2014():608930. PubMed ID: 24971371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Leukotriene-receptor antagonists: a new therapeutic principle in bronchial asthma?].
    Pforte A
    Dtsch Med Wochenschr; 1996 Sep; 121(37):1111-2. PubMed ID: 8925724
    [No Abstract]   [Full Text] [Related]  

  • 59. [Leukotriene antagonists. A new therapeutic approach in asthma].
    Chanez P; Bougeard YH; Vachier I; Godard P
    Presse Med; 1997 Feb; 26(5):234-9. PubMed ID: 9122118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.
    Lima JJ
    Mol Diagn Ther; 2007; 11(2):97-104. PubMed ID: 17397245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.